Folgen
Paolo Bonfanti
Paolo Bonfanti
Bestätigte E-Mail-Adresse bei unimib.it
Titel
Zitiert von
Zitiert von
Jahr
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ...
Science 370 (6515), eabd4585, 2020
24072020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ...
Science 370 (6515), eabd4570, 2020
20942020
Genomewide association study of severe Covid-19 with respiratory failure
Severe Covid-19 GWAS Group
New England Journal of Medicine 383 (16), 1522-1534, 2020
18342020
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7002021
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study
A Coppo, G Bellani, D Winterton, M Di Pierro, A Soria, P Faverio, M Cairo, ...
The Lancet Respiratory Medicine 8 (8), 765-774, 2020
5512020
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
4222021
High rates of 30-day mortality in patients with cirrhosis and COVID-19
M Iavarone, R D'Ambrosio, A Soria, M Triolo, N Pugliese, P Del Poggio, ...
Journal of hepatology 73 (5), 1063-1071, 2020
3812020
An immune-based biomarker signature is associated with mortality in COVID-19 patients
MS Abers, OM Delmonte, EE Ricotta, J Fintzi, DL Fink, AAA de Jesus, ...
JCI insight 6 (1), 2021
3202021
Hospital-acquired infections in critically ill patients with COVID-19
G Grasselli, V Scaravilli, D Mangioni, L Scudeller, L Alagna, M Bartoletti, ...
Chest 160 (2), 454-465, 2021
3192021
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
3162021
Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program
Mind Exchange Working Group, A Antinori, G Arendt, I Grant, S Letendre, ...
Clinical Infectious Diseases 56 (7), 1004-1017, 2013
2212013
Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients
M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ...
The Journal of infectious diseases 211 (2), 178-186, 2015
2172015
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian …
A Di Castelnuovo, M Bonaccio, S Costanzo, A Gialluisi, A Antinori, ...
Nutrition, Metabolism and Cardiovascular Diseases 30 (11), 1899-1913, 2020
1902020
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels
TM Snyder, RM Gittelman, M Klinger, DH May, EJ Osborne, R Taniguchi, ...
MedRxiv, 2020
1832020
Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study
P Bonfanti, L Valsecchi, F Parazzini, S Carradori, L Pusterla, P Fortuna, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 23 (3), 236-245, 2000
1732000
HIV and metabolic syndrome: a comparison with the general population
P Bonfanti, C Giannattasio, E Ricci, R Facchetti, E Rosella, M Franzetti, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 45 (4), 426-431, 2007
1462007
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
F Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ...
Journal of translational medicine 18 (1), 405, 2020
1452020
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 …
A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ...
Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015
1402015
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
R D'Ambrosio, L Pasulo, M Puoti, M Vinci, M Schiavini, S Lazzaroni, ...
Journal of hepatology 70 (3), 379-387, 2019
1282019
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ...
Proceedings of the National Academy of Sciences 119 (21), 2022
1242022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20